Exclusive: Biotech startup Profluent says it has found “scaling laws” for AI models for protein design

A photo illustration depicting gene editing. Using its new ProGen3 AI model, biotech startup Profluent has developed new gene editing proteins that may be more effective than the CRISPR-Cas9 systems that underpin most contemporary gene editing therapies.

Photo illustration—Getty Images